DMII · Drugs Made In America Acquisition II Corp.
$10.11
+0.00 (+0.00%)
At close · Aug 5
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with our assessment of going concern considerations in accordance with Financial Accounting Standard Board's Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$644.01M
Shares
63.70M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
$4.19M
FY2025
Operating Cash Flow
-$1.02M
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 |
|---|---|
| $488.39K | |
| $488.39K | |
| -$488.39K | |
| $4.93M | |
| $4.68M | |
| $4.19M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Key facts
CIK
2040475
CUSIP
G2851K104
13F (30d)
8 filings
8 filers